Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2010111149PMID 21737546PMCID PMC3137572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical examination of cyclooxygenase-2 and renin in a KK-A(y) mouse model of diabetic nephropathy.

  2010cited by this paper
• Mouse models of diabetic nephropathy.

  2009cited by this paper
• Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression.

  2009cited by this paper
• Distinct roles for basal and induced COX-2 in podocyte injury.

  2009cited by this paper
• (Pro)Renin Receptor Peptide Inhibitor “Handle-Region” Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats

  2008cited by this paper
• The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?

  2008cited by this paper
• Prorenin and the (pro)renin receptor in ocular pathology.

  2008cited by this paper
• Activation of a local renin angiotensin system in podocytes by glucose.

  2008cited by this paper
• Aliskiren combined with losartan in type 2 diabetes and nephropathy.

  2008cited by this paper
• Diabetic Nephropathy: Mechanisms of Renal Disease Progression

  2008cited by this paper
• The (pro)renin receptor and the kidney.

  2007cited by this paper
• Overexpression of cyclooxygenase-2 predisposes to podocyte injury.

  2007cited by this paper
• Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.

  2007cited by this paper
• Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade.

  2007cited by this paper
• AGE, RAGE, and ROS in diabetic nephropathy.

  2007cited by this paper
• Puromycin Induces Reversible Proteinuric Injury in Transgenic Mice Expressing Cyclooxygenase-2 in Podocytes

  2007cited by this paper
• The podocyte: a potential therapeutic target in diabetic nephropathy?

  2007cited by this paper
• Elevated Blood Pressure and Heart Rate in Human Renin Receptor Transgenic Rats

  2006cited by this paper
• Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.

  2006cited by this paper
• Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system.

  2006cited by this paper
• Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

  2006cited by this paper
• Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats.

  2006cited by this paper
• Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment

  2006cited by this paper
• Impact of genetic background on nephropathy in diabetic mice.

  2006cited by this paper
• The renin-angiotensin system in glomerular podocytes: Mediator of glomerulosclerosis and link to hypertensive nephropathy

  2006cited by this paper
• Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

  2006cited by this paper
• The Podocyte: A Major Player in the Development of Diabetic Nephropathy?

  2005cited by this paper
• Up‐regulation of cyclooxygenase‐2 during acute human renal allograft rejection

  2005cited by this paper
• Mouse models of diabetic nephropathy.

  2005cited by this paper
• High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells.

  2004cited by this paper
• Activation of a local tissue angiotensin system in podocytes by mechanical strain.

  2004cited by this paper
• Immunohistochemical Expression of Cyclooxygenase-2 in Normal Kidneys

  2004cited by this paper
• Expression of cyclooxygenases during renal allograft rejection.

  2004cited by this paper
• Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.

  2004cited by this paper
• Cyclooxygenase-2 and the renal renin-angiotensin system.

  2004cited by this paper
• Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes.

  2003cited by this paper
• Is podocyte injury relevant in diabetic nephropathy? Studies in type 2 diabetic patients.

  2003cited by this paper
• Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

  2003cited by this paper
• Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose.

  2003cited by this paper
• Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.

  2002cited by this paper
• Cyclooxygenase-2 Expression in Cultured Cortical Thick Ascending Limb of Henle Increases in Response to Decreased Extracellular Ionic Content by Both Transcriptional and Post-transcriptional Mechanisms

  2002cited by this paper
• Technical Advance A New Method for Large Scale Isolation of Kidney Glomeruli from Mice

  2002cited by this paper
• Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension.

  2002cited by this paper
• Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes.

  2001cited by this paper
• Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition.

  2001cited by this paper
• Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.

  2000cited by this paper
• Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus

  1999cited by this paper
• Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.

  1997cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1994cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus.

  1990cited by this paper
• Human prorenin: pathophysiology and clinical implications.

  1988cited by this paper
• Human prorenin: pathophysiology and clinical implications.

  1988cited by this paper

• Design and synthesis of new 1,4-naphthoquinones appended sulfenylated thiazoles as cyclooxygenase II inhibitors: Exploring the utility in the development of anticancer agents.

  2025cites this paper
• The Therapeutic Effect and Mechanism of Traditional Chinese Medicine in Type 2 Diabetes Mellitus and Its Complications

  2025cites this paper
• Understanding Diabetes Mellitus: Complications, Novel targets and Advancement in Treatment Strategies

  2025cites this paper
• (-)-Gallocatechin Gallate Mitigates Metabolic Syndrome-Associated Diabetic Nephropathy in db/db Mice

  2024cites this paper
• Principle role of the (pro)renin receptor system in cardiovascular and metabolic diseases: An update.

  2024cites this paper
• The effectiveness of antioxidant agents in delaying progression of diabetic nephropathy: A systematic review of randomized controlled trials

  2024cites this paper
• Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases

  2024cites this paper
• Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy

  2024cites this paper
• Analysis of the association between serum levels of 25(OH)D, retinol binding protein, and Cyclooxygenase‐2 and the disease severity in patients with diabetic foot ulcers

  2023cites this paper
• Dynamics of action of a Lys-49 and an Asp-49 PLA2s on inflammasome NLRP3 activation in murine macrophages.

  2022cites this paper
• Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition

  2022cites this paper
• Mechanism of Tripterygium wilfordii Hook.F.- Trichosanthes kirilowii Maxim decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking

  2022cites this paper
• Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy

  2022cites this paper
• A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms.

  2022cites this paper
• The Pathological Role of Pro(Renin) Receptor in Renal Inflammation

  2021cites this paper
• Pathophysiology of diabetes mellitus and its complications: Metabolic events and control

  2021cites this paper
• Nicotine, Smoking, Podocytes and Diabetic Nephropathy.

  2021cites this paper
• Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ deficiency kidney disease.

  2021cites this paper
• Antioxidant Effects and Mechanisms of Medicinal Plants and Their Bioactive Compounds for the Prevention and Treatment of Type 2 Diabetes: An Updated Review

  2020cites this paper
• Modulation of proteomic and inflammatory signals by Bradykinin in podocytes

  2020cites this paper
• Zingerone produces antidiabetic effects and attenuates diabetic nephropathy by reducing oxidative stress and overexpression of NF-κB, TNF-α, and COX-2 proteins in rats

  2020cites this paper
• The emerging role of COX-2, 15-LOX, and PPARγ in metabolic diseases and cancer: An introduction to novel multi-target directed ligands (MTDLs).

  2020cites this paper
• The interaction partners of (pro)renin receptor in the distal nephron

  2020cites this paper
• Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease

  2020cites this paper
• Aspirin attenuates podocyte injury in diabetic rats through overriding cyclooxygenase-2-mediated dysregulation of LDL receptor pathway

  2019cites this paper
• Identification of potential therapeutic target genes in mouse mesangial cells associated with diabetic nephropathy using bioinformatics analysis

  2019cites this paper
• MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor

  2019cites this paper
• Iguratimod (T-614) attenuates severe acute pancreatitis by inhibiting the NLRP3 inflammasome and NF-κB pathway.

  2019cites this paper
• Cardio-renal safety of non-steroidal anti-inflammatory drugs.

  2019cites this paper
• The (pro)renin receptor in health and disease

  2019cites this paper
• Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice.

  2019cites this paper
• Protective Effect of Safflower Seed on Cisplatin-Induced Renal Damage in Mice via Oxidative Stress and Apoptosis-Mediated Pathways.

  2018cites this paper
• Prostaglandins in the pathogenesis of kidney diseases

  2018cites this paper
• miR‐370 promotes high glucose‐induced podocyte injuries by inhibiting angiotensin II type 1 receptor‐associated protein

  2018cites this paper
• Glyoxalase 1 Modulation in Obesity and Diabetes

  2018cites this paper
• Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome.

  2018cites this paper
• (Pro)renin receptor activation increases profibrotic markers and fibroblast‐like phenotype through MAPK‐dependent ROS formation in mouse renal collecting duct cells

  2017cites this paper
• Foxc1 and Foxc2 are necessary to maintain glomerular podocytes

  2017cites this paper
• EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease

  2017cites this paper
• Transforming growth factor-β1 and phosphatases modulate COX-2 protein expression and TAU phosphorylation in cultured immortalized podocytes

  2017cites this paper
• Effect of the oral iron chelator deferiprone in diabetic nephropathy rats

  2017cites this paper
• Diabetic nephropathy: New insights into established therapeutic paradigms and novel molecular targets.

  2017cites this paper
• Heat-Processed Scutellariae Radix Protects Hepatic Inflammation through the Amelioration of Oxidative Stress in Lipopolysaccharide-Induced Mice.

  2017cites this paper
• Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.

  2017influential citation
• Interaction of the renin angiotensin and cox systems in the kidney.

  2016cites this paper
• Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy

  2016cites this paper
• The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats

  2016cites this paper
• Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy

  2016cites this paper
• The Alternative Renin-Angiotensin System: exploration of its therapeutic potential

  2015cites this paper
• Role of COX-2/mPGES-1/Prostaglandin E2 Cascade in Kidney Injury

  2015cites this paper
• Lipid Mediators Are Critical in Resolving Inflammation: A Review of the Emerging Roles of Eicosanoids in Diabetes Mellitus

  2015cites this paper
• DJ-1 regulates the expression of renal (pro)renin receptor via reactive oxygen species-mediated epigenetic modification.

  2015cites this paper
• Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy

  2015cites this paper
• Crosstalk between (Pro)renin receptor and COX-2 in the renal medulla during angiotensin II-induced hypertension.

  2015cites this paper
• (Pro)renin receptor regulates autophagy and apoptosis in podocytes exposed to high glucose.

  2015cites this paper
• Cyclooxygenase‐2 Regulates NLRP3 Inflammasome‐Derived IL‐1β Production

  2015cites this paper
• Impact of socio-demographic factors on comorbidity burden in diabetes mellitus patients: a comprehensive inpatient population-based analysis

  2015cites this paper
• Albumin-induced podocyte injury and protection are associated with regulation of COX-2.

  2014cites this paper
• Extract of Cassiae semen attenuates diabetic nephropathy via inhibition of advanced glycation end products accumulation in streptozotocin-induced diabetic rats.

  2014cites this paper
• Urinary messenger RNA of the receptor activator of NF-kappaB could be used to differentiate between minimal change disease and membranous nephropathy

  2014cites this paper
• Chinese prescription Kangen-karyu and Salviae Miltiorrhizae Radix improve age-related oxidative stress and inflammatory response through the PI3K/Akt or MAPK pathways.

  2014cites this paper
• New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy

  2014cites this paper
• The Role of MicroRNAs in Diabetic Nephropathy

  2014cites this paper
• Roles of the (pro)renin receptor in the kidney.

  2014cites this paper
• High Glucose Induces Podocyte Injury via Enhanced (Pro)renin Receptor-Wnt-β-Catenin-Snail Signaling Pathway

  2014cites this paper
• The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats

  2013cites this paper
• Renin inhibition in the treatment of diabetic kidney disease.

  2013cites this paper
• Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6

  2013cites this paper
• Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.

  2013cites this paper
• Mechanisms of diabetic complications.

  2013cites this paper
• Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor.

  2013cites this paper
• Beneficial Effect of 7-O-Galloyl-D-sedoheptulose, a Polyphenol Isolated from Corni Fructus, against Diabetes-Induced Alterations in Kidney and Adipose Tissue of Type 2 Diabetic db/db Mice

  2013cites this paper
• Key developments in renin–angiotensin–aldosterone system inhibition

  2013cites this paper
• The intracrine renin-angiotensin system.

  2012cites this paper
• Drug discovery for diabetic nephropathy: trying the leap from mouse to man.

  2012cites this paper
• SPECIAL TOPIC Intracrine Renin-Angiotensin System: A New Paradigm in Cardiovascular and Renal Control Functional intracellular renin-angiotensin systems: potential for pathophysiology of disease

  2012cites this paper
• Kidney proximal tubular epithelial-specific overexpression of netrin-1 suppresses inflammation and albuminuria through suppression of COX-2-mediated PGE2 production in streptozotocin-induced diabetic mice.

  2012cites this paper
• (Pro)renin and its receptors: pathophysiological implications.

  2012cites this paper
• University of Groningen Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients

  2012cites this paper
• W ( Pro ) renin and its receptors : pathophysiological implications

  2012cites this paper
• Receptor Activator of NF-kappaB and Podocytes: Towards a Function of a Novel Receptor-Ligand Pair in the Survival Response of Podocyte Injury

  2012cites this paper
• Functional intracellular renin-angiotensin systems: potential for pathophysiology of disease.

  2012cites this paper
• Intracrine Renin-Angiotensin System : A New Paradigm in Cardiovascular and Renal Control Functional intracellular renin-angiotensin systems : potential for pathophysiology of disease

  2012cites this paper
• The (pro)renin receptor. A decade of research: what have we learned?

  2012cites this paper
• Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis

  2012cites this paper
• 7‐O‐Galloyl‐d‐sedoheptulose ameliorates renal damage triggered by reactive oxygen species‐sensitive pathway of inflammation and apoptosis

  2012cites this paper
• The prorenin receptor: what's in a name.

  2011cites this paper
• The Journal of Toxicological Sciences

  2009cites this paper